Comments
Pursuant to Regulation 33 and 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we would like to inform you that the Board of Directors in its meeting held on Tuesday, August 07, 2018 at 06:00 p.m. at Factory Conference Room, GlaxoSmithKline Consumer Healthcare Limited, Patiala Road, Nabha 147201 (Punjab) have, inter alia, considered and taken on record the Unaudited Financial Results for the quarter ended June 30, 2018. We are enclosing a copy of the Unaudited Financial Results for the quarter ended June 30, 2018 along with the Limited Review Certificate, issued by the Auditors for the review done by them, for your records.
Source : BSE - www.bseindia.com
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.